Fox Business - The Power to Prosper
Search Site

Pfizer

Related Topics

  1. King Pharmaceuticals
  2. Wyeth
  3. Pharmaceuticals
  4. Lowe's
  5. IMS Health
  6. Vertex Pharmaceuticals
Get updates on Pfizer
FBI: NSA Helped Foil NYSE Bombing Plot

FBN's Liz MacDonald on the FBI using Internet and phone surveillance to stop an NYSE bombing plot.

Read More ›

  1. Stock Futures Rebound from Selloff

    FOX Business: Capitalism Lives HereU.S. stock-index futures climbed on Wednesday as traders looked to scoop up shares that were beaten down in the previous session o...

  2. Stocks Bounce Back; Corporate News in Focus

    FOX Business: Capitalism Lives HereThe markets posted mild gains on Wednesday as traders grabbed shares at a discount following a selloff in the last session. Today'...

  3. Dow Whipsawed in First Three-Day Slump of '13

    FOX Business: Capitalism Lives HereThe Dow swung in a 200-point range Wednesday, finally selling off in its first three-day losing streak of the year. Today's Market...

  4. Is the NSA monitoring emails?

    Senator Rand Paul reacts to the NSA surveillance leak

  5. FNC Video

    null

  6. House lawmakers to be briefed on NSA snooping

    Rep. Justin Amash weighs in

  7. Obama answers questions about government surveillance

    Big brother gone too far?

  8. FDA's flawed call on Aveo's Tivozanib

    By Chris ReesWhen the FDA got together with the Oncologic Drugs Advisory Committee (ODAC) in early May to discuss whether to approve Aveo Pharmaceutical's (AVEO) Tiv...

  9. NSA mines data from top Internet companies

    Has the agency overextended its reach?

  10. Should Americans trust the NSA with private information?

    Newt Gingrich discusses the agency's spying

  11. Judge sets November 4 insider trading trial for SAC's Martoma

    A federal judge on Wednesday set a November 4 start for the criminal trial of Mathew Martoma, a former portfolio manager at hedge fund SAC Capital Advisors, on insid...

  12. Merck Discontinues Studies on Preladenant Drug

    Merck & Co. (MRK) said it is discontinuing the clinical program for its preladenant drug to treat Parkinson's disease after an initial review of data from three sepa...

  1. Interesting Similarities Among 2013's Top-Performing ETFs

    With 2013 nearly half complete, now is a good time to look at this year's top-performing ETFs to see what has worked, what might keep working and which funds could b...

  2. FNC Video

    FNC Video

  3. Shareholder Lawsuit Against SAC Takes Next Step

    A New York court designated a pension fund as the lead plaintiff in a lawsuit filed by shareholders of Elan Corp against SAC Capital, a court filing showed, as the h...

  4. Swanky Corporate Events Make Post-Recession Comeback

    While lavish corporate events five years ago drew a negative stigma that executives tried desperately to avoid, new data show resorts are making a post-recession com...

  5. Pfizer Gets $2.15B from Teva, Sun In Protonix Settlement

    FBN’s Diane Macedo breaks down the stories moving the markets ahead of the trading day.

  6. Pfizer Wins $2.15B Patent Suit with Teva, Sun Pharma

    Pfizer (NYSE:PEF) won a $2.15 billion settlement with Teva Pharmaceuticals (NYSE:TEVA) and Sun Pharma on Tuesday for patent-infringement related to its acid-reflux d...

  7. Pfizer Wins $2.15 Bln Settlement From Teva And Sun

    Pfizer Inc. said Wednesday that it reached a settlement with Teva Pharmaceuticals Industries and Sun Pharmaceutical Industries over patent infringement. The $2.15 bi...

‹ Prev12345…Next ›
Freebase CC-BY
Source: Pfizer on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL